chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This non-serious medically confirmed spontaneous report (initial receipt 20-Nov-2014) concerns a 70 year-old female patient who previously received flu vaccine (unknown if AFLURIA was administered) and experienced high temperatures, chills, fatigue, severe joint aches and generalized body pain (see case 2014046773). On 15-Oct-2014 at 14:50 hours, the patient received intramuscular AFLURIA vaccine (batch number 10149211A) 0.5mL. On the same day as the AFLURIA vaccine, 15-Oct-2014, some hours later, the patient experienced high temperatures, chills, fatigue, severe achiness especially in the joints, and all over generalized body pain for 24-36 hours. She stayed in bed for the entire evening. On 16-Oct-2014, she went to work where it was confirmed that her temperature was 101.7 degrees Fahrenheit. She was sent home where she remained in bed to rest. Her primary care provider was aware and she was advised to take acetaminophen or ibuprofen for the achiness. On 17-Oct-2014, she felt better. All the signs and symptoms resolved. Outcome was recovered on 17-Oct-2014. Reporter Comments: Reporter stated that she did not if the patient's concomitant medications, medical history, height and weight.
Muscle aches, malaise, chills, 120 to 140 bpm heart rate and perfuse sweating which lasted from dinner, allnight until early morning.  Drank a lot of water and stretched to help relax and tried to call back asleep.  Heart rate did eventually go back down to 80 to 90 bpm.  Still felt clamy and fatigued.  Went to work with little energy.
Shortly after receiving  the vaccine while waiting patient lost consciousness for a few second and gained consciousness.  911 was called but patient and mom refused to go to the hospital.  Patient left shortly after.  She said she felt better.
10:30 Itchy and numbness in injection enter right arm, then itchy on other left arm - no hives BENADRYL 50 mg IM - left deltoid.
Headache, Myalgia, Arthralgia, Fever, UrticariaPruritus, chills/ fatigue/ swollen glands Narrative:
P/receiving an inject of Typhoid vax, pt devel a large 6cm area of erythema, edema, & induration @ the inject site w/phlebitis extending into the axilla; Additionally, inflamed & swollen underarm lymph nodes were observed;
Pt administered VARIVAX #2 sc right deltoid on 3/18/14. Later in evening pt noted redness at site. Had appt here to check this 3/19/14, then again on 3/20/14. As of 3/20/14 erythema present at site 7x8cm pt being treated for cellulitis with KEFLEX.  7 x 8 cm macular erythema at site.
states approx 15 mins p/vax pt became very warm & did not feel good; states for next 2 wks p/inject had hot flashes & skin was hot to touch; states felt flu-like & cold sx; has a twin sister who is allergic to yeast;
Condition aggravated; Blister; Cough; Ache; Sniffles; Body temperature increased; This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (Condition aggravated), BLISTER (Blister), COUGH (Cough), PAIN (Ache) and RHINORRHOEA (Sniffles) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis and Hidradenitis suppurativa.    No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) CF. In 2021, the patient experienced PAIN (Ache), RHINORRHOEA (Sniffles) and BODY TEMPERATURE INCREASED (Body temperature increased). On an unknown date, the patient experienced CONDITION AGGRAVATED (Condition aggravated), BLISTER (Blister) and COUGH (Cough). At the time of the report, CONDITION AGGRAVATED (Condition aggravated), BLISTER (Blister) and COUGH (Cough) had not resolved and PAIN (Ache), RHINORRHOEA (Sniffles) and BODY TEMPERATURE INCREASED (Body temperature increased) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: Body temperature increased.         Concomitant drugs not reported. There was no reported medical history. For HUMIRA, the reporter causality for the events of Outbreaks and flare ups, Big lumps/could tell there was fluid on trunk and right breast and Cough was a reasonable possibility and the reporter causality for the events of Felt achy, Sniffles and patient had Mild temperature was not provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Treatment drugs not reported.   Reporter did not allow further contact
it feels inflamed; itching / at injection site; redness / at injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site inflammation in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included renal disease.   On 6th August 2021, the patient received the 1st dose of Shingrix. On 6th August 2021, less than a day after receiving Shingrix, the patient experienced injection site inflammation, injection site itching and injection site erythema. On an unknown date, the outcome of the injection site inflammation and injection site itching were unknown and the outcome of the injection site erythema was not recovered/not resolved.   It was unknown if the reporter considered the injection site inflammation, injection site itching and injection site erythema to be related to Shingrix.  Additional details were provided as follows: This case was reported by the patient herself. The patient reported that, she received her first Shingrix shot on Friday.  She experienced redness and itching at the injection site and stated that it felt inflamed.  The patient did not provide a lot number or expiration date. The reporter consented to follow up.
Reports 2 quarter size knots lt deltoid x 10 min p/inject; each knot approx 1" apart; upper arm became red, swollen & felt warm to touch; 9NOV91 pt noted sm clear fluid bumps; also itching of lt upper arm, irritability, t98.8;
pt devel a temp elevation on 21JUL93 in the afternoon; taken to the hosp & dx'd w/ear infect; placed on amoxicillin;
PANIC ATTACK; This spontaneous report received from a patient concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced panic attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of panic attack was not reported. This report was non-serious.
Tiredness- "not herself"- Day 1-5. Vomiting and Diarrhea- Day 2 & 3. Fever of 100.2 and Fussiness- Day 5. Cold symptoms- Day 7-8.
Women might have received a less dose than the recommended because she saw some liquid left in the syringe when the administration of the vaccine was ended; A spontaneous report was received from a consumer concerning a female patient (age unknown) who received Moderna's COVID-19 vaccine (mRNA-1273) and the woman thought that she might have received a less dose than the recommended because she saw liquid left in the syringe when the administration of the vaccine was ended.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On an unknown date, the patient received their first dose of MRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the woman thought that she might have received a less dose than the recommended because she saw liquid left in the syringe when the administration of the vaccine was ended. No treatment for the event was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, the woman thinks that she might have received a less dose than the recommended because she saw liquid left in the syringe when the administration of the vaccine was ended was not reported.; Reporter's Comments: This case concerns a female patient who received her first dose of MRNA-1273 intramuscularly for prophylaxis of COVID-19 infection and the woman thought that she might have received a less dose than the recommended because she saw liquid left in the syringe when the administration of the vaccine was ended. There were no reported adverse events after the vaccine was administered associated with the event of incorrect dose administered
Information has been received concerning a 38 year old male who was administered Fluzone SV 2002-2003 USP (Lot # U0944aa) on 11/06/2002.  Approximately 6 hours after vaccination, the pt experienced difficulty in verbalizing thoughts, which lasted for 2 to 3 hours.  He was fully recovered.  It was also reported that he had received influenza vaccine in the past with no problems.  From additional information received on 04/10/03, from a nurse, it was reported that the pt, vaccine administrator and physician's information be updated.  No further information is anticipated, this case is closed.
I purchased a new blood pressure machine, and I noticed it in August 2022. It's been as high as 160. My blood pressure was seldom over 120. I went to the doctor on November 28, and they prescribed amlodipine desolate that I have been taking daily but the blood pressure is still elevated. It was 160/82 last night when I checked it. I am asymptomatic; I only find out it is elevated when checking on my blood pressure cough.
pt recv vax 25APR97 & pt broke out w/chickenpox 28AUG97 was exposed to chickenpox 2wk ago;
Pt had decerebrate seizure like activity.  This lasted approx. 1-2 mins.  Pt was postictal for approximately 5 mins.  Pt remained Hypotensive and dizzy for approximately 25 mins until EMS arrived.
Initial report received from a Healthcare professional on 21 June 2012. A patient (age and gender- unknown), whose medical history and concomitant medications were not reported, had received dose of FLUZONE HD vaccine (batch number, route of administration and site of administration were not reported) on unspecified date. It was reported that the patient experienced increased adverse reactions (not specified) with FLUZONE HD vaccine. The patient had gone to the ER. Corrective treatment and laboratory investigations were unknown. As of 21 June 2012, the outcome of event was reported as unknown. The reporter does not correlate the ER visit with the vaccine. Documents held by sender: none.
After about a half an hour after the shot (on the way home), I noticed my left arm was tingling from the elbow down.  By day 2 both my arms and legs in their entirety and the lower right side of my face were tingling.  My ears were ringing more than usual.   My heart seemed to be beating a little fast.  My husband said I looked pale. I called my PCP.  His nurses relayed that this should  go away in 2-3 days,  It didn't.  It got much worse.  By day 3, my entire arms and legs had gone numb.  I have weird burning sensations in my insides and arms and legs that come and go.  Now after 5+ weeks I am beginning to get occasional cramps in my legs.  At times, my hands and feet are very cold.  I feel pain in my hands, feet, etc. It doesn't feel like it's getting any better.  It feels like it's getting worse.  It's worse at night with increased tingling and it's hard to get to sleep.  I've had ongoing discussions about these reactions  with various pharmacists both via e-mail and by phone.  I don't know if this is ever going away.  I didn't mark permanent damage below because I don't know yet.
This is a spontaneous report from a contactable pharmacist. A 72-year-old female patient received PREVNAR 13 (lot M51194, NDC number 00005197101, UPC number 300051971022, Expiry Date May 2017), on the right arm at 0.5 ml, single for prophylaxis and influenza vaccine FLUZONE, (lot UI63688, manufacturer Sanofi NDC number: 49281039988, UPC number: 34928139965, Expiry Date: 27Mar2017), on the left arm both on 23Sep2016 via intramuscular route for immunization. The patient medical history was not reported. There were no concomitant medications. On 24Sep2016 the patient experienced pain in arm that lasted for 4 weeks with outcome of not recovered and vaccination site pain on an unspecified date with outcome of recovered.
Lethargy following vaccination. Slept most of 4/27-4/28.  Rash developed on 3/29, left chest (same side as vaccination). Small red bumps. No treatment.  Severe arm pain on 4/3, woken up from sleep (left arm, same as vaccination). At home treatment:  1000mg ibuprofen, 0.5mL CBD, CBD m topical. Pain improved but persisting
PAIN IN NECK; JOINT PAIN/ MIDDLE FINGER JOINT PAIN; PAIN IN BOTH CHINS,SHOULDER, FOREARMS AND HANDS; PAIN IN BOTH ANKLES; HEADACHE; This spontaneous report received from a patient via a company representative concerned a 71 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included chin pain. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808982, and expiry: 23-JUN-2021) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 2021, the subject experienced pain in neck. On 2021, the subject experienced joint pain/ middle finger joint pain. On 2021, the subject experienced pain in both chins, shoulder, forearms and hands. On 2021, the subject experienced pain in both ankles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from joint pain/ middle finger joint pain, pain in neck, pain in both ankles, pain in both chins, shoulder, forearms and hands, and headache. This report was non-serious.
Pt went to Urgent Care with complaints of swollen eyes, slight hives, headache, earache, weakness and rapid heart beat. Pt states, she was given Kenalog and "another shot" to combat reaction"; also had face swelling, vomiting and diarrhea. Pt took OTC Benadryl before going to MD.
Boostrix was accidentally given instead of Flulaval; Boostrix was accidentally given to a 9 year old female patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 9-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 25A2F, expiry date 19-JAN-2026) for prophylaxis.   On 18-OCT-2023, the patient received Boostrix. On 18-OCT-2023, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: Boostrix was accidentally given instead of Flulaval) and inappropriate age at vaccine administration (Verbatim: Boostrix was accidentally given to a 9 year old female patient). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 18-OCT-2023 A nurse reported that Boostrix was accidentally given instead of Flulaval to a 9 year old female patient which led to inappropriate age at vaccine administration and wrong vaccine administered. The healthcare professional notes that the error occurred because it was given to the wrong sibling. The reporter consented to follow up via mail.
pt's mom states pt recvd vax & lt arm became painful, swollen, hard to move; mom giving APAP;
Pt has 2 pustules from previous vaccine site from 5/03. Revaccinated 7/15/03. Recheck 7/21/03 right arm-no symptoms. Pt came in because she was not feeling well-generally.
Patient received her second dose of the Shingrix vaccine and noticed redness/swelling/hottness around the injection site, starting the following day. She went to her primary care doctor two days later who prescribed her Cephalexin for the reaction.
excruciating kidney pain; couldn't stand up straight had to walk at 45 degree angle, totally bent over, in agony, as if someone was pulling out my kidneys; fluid in throat was so thick I couldn't expel it; This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (excruciating kidney pain), POSTURE ABNORMAL (couldn't stand up straight had to walk at 45 degree angle, totally bent over, in agony, as if someone was pulling out my kidneys) and OROPHARYNGEAL DISCOMFORT (fluid in throat was so thick I couldn't expel it) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced RENAL PAIN (excruciating kidney pain), POSTURE ABNORMAL (couldn't stand up straight had to walk at 45 degree angle, totally bent over, in agony, as if someone was pulling out my kidneys) and OROPHARYNGEAL DISCOMFORT (fluid in throat was so thick I couldn't expel it). At the time of the report, RENAL PAIN (excruciating kidney pain) and OROPHARYNGEAL DISCOMFORT (fluid in throat was so thick I couldn't expel it) had not resolved and POSTURE ABNORMAL (couldn't stand up straight had to walk at 45 degree angle, totally bent over, in agony, as if someone was pulling out my kidneys) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
High fever, fatigue, nausea, lethargy, missed school the reaction to this vaccine was so bad - no other reactions to report YET
severe discoloration in her skin that has not gone away, she has a different skin tone in her upper left arm, like a tan. It is like a big blob, not a perfect circle; feeling pain at the injection site the day the vaccine was administered; mentioned it is big blob not a perfect circle; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 52-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 30Sep2023 at 17:00 as dose 1, single (Batch/Lot number: unknown) at the age of 51 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Moderna (Primary immunization series completed), for COVID-19 immunization. The following information was reported: RASH (non-serious) with onset 2023, outcome "not recovered", described as "mentioned it is big blob not a perfect circle"; VACCINATION SITE PAIN (non-serious) with onset 30Sep2023, outcome "not recovered", described as "feeling pain at the injection site the day the vaccine was administered"; SKIN DISCOLOURATION (non-serious) with onset 01Oct2023, outcome "not recovered", described as "severe discoloration in her skin that has not gone away, she has a different skin tone in her upper left arm, like a tan. It is like a big blob, not a perfect circle". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vaccination site pain, skin discolouration, rash.  Additional Information: t was reported that All her previous COVID-19 vaccination had been Moderna. She refers feeling pain at the injection site the day the vaccine was administered and putting an ice pack on her arm. The day after the vaccine, she noted severe discoloration in her skin that has not gone away, she has a different skin tone in her upper left arm, like a tan. It is like a big blob, not a perfect circle. It is not harmful. Her husband told her it was bruising but it has been three weeks and it has not gone away. She has applied coconut oil and creams with no results. Asks if this has been reported.   The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Started spotting 15 days early before period was due immediately after getting the vaccine. Got the second vaccine and period started to be heavy and lasted for over 30 days. Since then, period is heavy and lasts 20-30 days per month.
Pityriasis rosea, Acyclovir 400mg Tablets Clobetasol Prop 0.05% Cream 30gm  Cleared up about 1 month later
Brain fog; Calf muscles cramps; foot cramps; Fatigue; Headache; Body ache; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8713) via an unspecified route of administration in the arm right on 20Apr2021 at 15:00 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was diagnosed with COVID-19 prior to vaccination. Concomitant medication included unspecified medication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 30Mar2021 at 15:00 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 10:00, the patient experienced calf muscles cramps, foot cramps, fatigue, headache, body ache and brain fog. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events calf muscles cramps, foot cramps, fatigue, headache, body ache and brain fog was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient developed swollen hands and swollen ankles/feet that was visually noticeable approximately 2 to 3 hours after receiving vaccine. Onsite staff noticed the symptoms and sent the patient immediately to the local Emergency Department for further examination and treatment. The patient did not show signs of severe anaphylaxsis (oral-facial swelling/difficulty breathing).
Since three days after getting vaccine I?ve had worsening daily migraines with lightheadedness. Daily migraines pre vaccine were 1/2 a day usually and post vaccine are 3-12 per day. The number is so high because they dont last very long.
Sudden & severe dizziness/loss of balance at initial event.  Slight dizziness or general feeling of being in a slight haze has occurred since then with small occasional episodes of slight loss of balance.
Chills in evening and through the night, all over body aches, sore arm - unable to raise, headache throughout the day and night.
no adverse effects; received one dose of MMR II intramuscularly instead of subcutaneously; This spontaneous report was received from a nurse practitioner, who refers to herself, a female patient of an unknown age. No information regarding patient's pertinent medical history, drug reactions or allergies and concomitant medications was reported.  On 13-MAY-2019, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), intramuscularly (instead of subcutaneously), (exact dose, injection site, lot# and expiration date were not provided) for prophylaxis. The administered vaccine was diluted in sterile diluent, intramuscularly (instead of subcutaneously), (exact dose, injection site, lot# and expiration date were not provided) for prophylaxis.  There was no adverse event reported.
Pt recvd 2nd dose of hep B vax 11JAN91 & exp pain,warmth & black & blue marks @ inject site.